News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • ASML raised its 2026 revenue guide to €43–45B and is increasing capacity 30%, signaling stronger AI-driven capex demand.
  • Assembly Biosciences secured a Gilead collaboration and positive Phase 1b readouts, positioning for Phase 2 catalysts and deal upside.
  • IBM plunged after weak Z mainframe results and now trades near its 52-week low while still yielding over 3% and generating free cash flow.
  • MSCI’s high-margin index and analytics franchises support a long-biased trade despite a rich valuation and low churn.
  • Robinhood’s pullback near $100 is viewed as a buying opportunity ahead of the Robinhood Chain launch and diversified revenue growth.
  • Circle’s USDC benefits from network effects and payments integrations, suggesting new stablecoins will expand overall dollar-token demand.
  • XFLT faces a proxy contest as the board backs King Street to replace Octagon after poor NAV performance and multiple CLO defaults.

Latest Articles

Cerebras Shares Climb as Nine Banks Begin Buy-Focused Coverage

Cerebras Shares Climb as Nine Banks Begin Buy-Focused Coverage

Cerebras Systems (NASDAQ: CBRS) rose 4% after nine major brokerages initiated coverage following the end of the company's post-IPO quiet period. Analysts emphasized Cerebras' wafer-scale Wafer-Scale Engine (WSE), its advantage in fast inference, and sizable commercial contracts with OpenAI and AWS as the basis for aggressive revenue and market-size…

Cognizant Shares Rise After Wedbush Upgrade Citing AI Builder Momentum

Cognizant Shares Rise After Wedbush Upgrade Citing AI Builder Momentum

Cognizant Technology Solutions jumped in pre-market trading after Wedbush upgraded the stock to Outperform and boosted its price target from $56 to $70. The broker highlighted accelerating traction for Cognizant's AI Builder initiative, a 70% increase in total contract value and the prospect that large enterprise deals will convert to revenue in th…

Why Broadcom's Pullback Is a Buying Opportunity, Not a Breakdown

Why Broadcom's Pullback Is a Buying Opportunity, Not a Breakdown

Broadcom (AVGO) has pulled back sharply, but beneath the headline volatility the company retains durable secular advantages, strong free cash flow, and enterprise exposure that should support a recovery. This is a tactical long trade that aims to capture mean reversion into value and upcoming catalysts while keeping position risk-defined.

BofA: Another 2% Drop in Nasdaq Could Force Wider CTA Liquidations

BofA: Another 2% Drop in Nasdaq Could Force Wider CTA Liquidations

Bank of America warns that Friday's steep fall in the Nasdaq-100 appears to have initiated a coordinated reduction in systematic long equity exposures, and that an additional decline of roughly 90 basis points to 2% could prompt broader CTA deleveraging. The bank highlights record selling from leveraged and inverse ETFs, historically elevated SPX g…

Anfield Energy Provides Operational Update on Shootaring Canyon Uranium Mill License Renewal and Refurbishment

Anfield Energy Provides Operational Update on Shootaring Canyon Uranium Mill License Renewal and Refurbishment

Anfield Energy Inc. provides an operational update on the Shootaring Canyon Uranium Mill license renewal and refurbishment progress in Utah. Key milestones include drilling monitoring wells, starting leach tank removal, progressing engineering designs, and constructing a new man camp. These efforts aim to complete license renewal by year-end and re…

Ambow Education to Host HybriU™ Open House at NewSchool of Architecture and Design During AIA Conference on Architecture & Design 2026 in San Diego

Ambow Education to Host HybriU™ Open House at NewSchool of Architecture and Design During AIA Conference on Architecture & Design 2026 in San Diego

Ambow Education Holding Ltd. (NYSE American: AMBO) announced it will host a multi-day Open House event at the NewSchool of Architecture and Design during the AIA Conference on Architecture & Design 2026 in San Diego. The event will showcase Ambow's patented AI-powered phygital platform, HybriU™, which enables real-time, immersive collaboration and …

Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

Ceribell announced the publication of a pivotal research paper in Critical Care Medicine demonstrating that their Clarity AI algorithm’s measurement of seizure burden strongly correlates with neurological outcomes at discharge. The study, conducted across three academic medical centers on 359 patients, shows that higher seizure burden detected by C…

Eldorado Gold Announces First Concentrate Produced at McIlvenna Bay

Eldorado Gold Announces First Concentrate Produced at McIlvenna Bay

Eldorado Gold Corporation announced the production of the first copper concentrate at its 100%-owned McIlvenna Bay Project in Saskatchewan, Canada. This milestone marks a key step towards achieving commercial production targeted for Q3 2026. The project diversifies Eldorado's portfolio by adding copper and zinc exposure and enhances its Canadian op…

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

Eledon Pharmaceuticals announced updated data from an investigator-initiated trial at UChicago Medicine demonstrating that all 12 patients with Type 1 Diabetes undergoing islet transplantation achieved insulin independence and improved glycemic control using tegoprubart, a novel anti-CD40L antibody. The calcineurin inhibitor-free regimen showed exc…

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion, Inc., a Nasdaq-listed healthcare technology company specializing in chronic low back pain diagnostics, announced that its stockholders approved all proposals at the 2026 Annual Meeting, including board member elections, auditor appointment, and equity plan amendments. The company reported 196% year-over-year growth in its Nociscan scan vo…

Concorde International Group Enters Exclusive Partnership with TrackerHero, Onboarding Its Business Model–Driven, Technology-Enabled Facilities Security Operations

Concorde International Group Enters Exclusive Partnership with TrackerHero, Onboarding Its Business Model–Driven, Technology-Enabled Facilities Security Operations

Concorde International Group Ltd. (NASDAQ: YOOV), a provider of technology-enabled security solutions, has entered into an exclusive strategic partnership with Malaysia-based TrackerHero to integrate TrackerHero's AI and IoT-powered digital patrol management system, THPatrol, into Concorde's facilities security operations in Singapore. The collabor…

Brady Corporation Announces CEO Transition

Brady Corporation Announces CEO Transition

Brady Corporation announced that Russell Shaller will retire after 11 years as CEO and board member, with Vineet Nargolwala appointed as the new CEO effective June 8, 2026. Nargolwala brings extensive experience in technology and public companies and will lead Brady through its major acquisition of Honeywell’s Productivity Solutions and Services bu…

EHang Announces US$30 Million Share Repurchase Program

EHang Announces US$30 Million Share Repurchase Program

EHang Holdings Limited, a leading advanced air mobility technology company listed on Nasdaq, announced a $30 million share repurchase program over the next 12 months. The company's board authorized buying back shares to demonstrate confidence in its long-term growth and value delivery to shareholders. The repurchase will be funded mainly from exist…

Upstream Bio to Showcase Additional Efficacy Data from the Phase 2 VIBRANT Trial of Verekitug in CRSwNP in Oral Session at EAACI 2026

Upstream Bio to Showcase Additional Efficacy Data from the Phase 2 VIBRANT Trial of Verekitug in CRSwNP in Oral Session at EAACI 2026

Upstream Bio announced that new data from its Phase 2 VIBRANT trial evaluating verekitug, a novel TSLP receptor antagonist monoclonal antibody, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) will be presented at the EAACI 2026 Congress. Verekitug is uniquely positioned as the only antagonist targeting the TSLP receptor in clinic…

Quantum Cyber Signs LOI to Acquire an Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility to Support Mass-Scale Autonomous Drone Production

Quantum Cyber Signs LOI to Acquire an Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility to Support Mass-Scale Autonomous Drone Production

Quantum Cyber N.V., a Nasdaq-listed autonomous defense technology company, announced its wholly owned subsidiary Quantum Drones Corporation has signed a Letter of Intent to acquire a manufacturing facility in Bridgeport, Connecticut. The acquisition supports the company's strategic shift from technology licensing to vertically integrated manufactur…

Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)

Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)

Mineralys Therapeutics announced new late-breaking data from its Phase 2 and Phase 3 trials showing that lorundrostat, a selective aldosterone synthase inhibitor, modulates heart failure risk biomarkers in patients with uncontrolled hypertension. The data will be presented at the Endocrine Society's annual meeting, highlighting lorundrostat's effic…

Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

Tonix Pharmaceuticals announced it has secured a second commercial payer agreement effective June 1, 2026, with a leading group purchasing organization (GPO), increasing commercial insurance coverage of its fibromyalgia drug TONMYA® to approximately 52 million U.S. lives. This milestone follows an earlier agreement and enhances patient access to th…